Avalyn Pharma Inc. Common Stock

NASDAQ:AVLN

Medical - Pharmaceuticals

Healthcare
$27.69 +1.77%

+$0.52 today

Market cap
$1.23B
Beta
0.00
52W Low $24.15High $32.23

Volume 0.40M

Average 0.51M

AVLN Accumulated OCI

Accumulated other comprehensive income: unrealized gains and losses, such as currency translation, recorded outside net income.

No reported Accumulated OCI figures are available to summarize.

Accumulated OCI history

Currency unavailable · from the balance sheet

No Accumulated OCI data reported for this period type.

Accumulated OCI vs competitors

How AVLN compares with its peers on the latest reported figures

AVLN Competitors
Accumulated OCI for AVLN and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
GYREGyre Therapeutics, Inc.Mar 2026$4.23M USD+591.8%—2.6%
VCREVicore Pharma Holding ABJun 2026SEK 0 SEK——0.0%
MNKDMannKind CorporationMar 2026-$4K USD-100.3%—0.0%
INSMInsmed IncorporatedJun 2026-$3.37M USD-294.7%+24.6%0.2%
AVLNAvalyn Pharma Inc. Common Stock—— ———
Peer median (excluding AVLN) —-100.3%+24.6%0.1%

Competitors are the stored peer set for AVLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Avalyn Pharma Inc. Common Stock

NASDAQ:AVLN

Intrinsic Alpha fair value

Locked

Current Price

$27.69

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.